MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
13.77
+1.10
+8.68%
Opening 15:42 08/14 EDT
OPEN
12.46
PREV CLOSE
12.67
HIGH
13.77
LOW
12.41
VOLUME
477.81K
TURNOVER
--
52 WEEK HIGH
15.35
52 WEEK LOW
6.62
MARKET CAP
1.28B
P/E (TTM)
-9.2478
1D
5D
1M
3M
1Y
5Y
1D
MeiraGTx Holdings Is Maintained at Outperform by RBC Capital
Dow Jones · 4h ago
MeiraGTx Holdings Price Target Raised to $27.00/Share From $26.00 by RBC Capital
Dow Jones · 4h ago
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $27
Benzinga · 4h ago
RBC Capital Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)
TipRanks · 7h ago
Bank of America Securities Remains a Buy on Meiragtx Holdings (MGTX)
TipRanks · 8h ago
Mitchell Kapoor Reiterates Buy on MeiraGTx, Maintains $20 12-Month Price Target on Clinical Progress and Strengthened Balance Sheet
TipRanks · 1d ago
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
NASDAQ · 1d ago
MeiraGTx Hldgs Q2 EPS $1.71 Beats $(0.46) Estimate, Sales $321.434M Beat $12.476M Estimate
Benzinga · 1d ago
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.